Silvercrest Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Silvercrest Asset Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-135,910	Closed	-$8.46M	–	924
2023 Q4	$8.46M	Buy	135,910 +26,150	+24%	+$1.46M	0.06%	272
2023 Q3	$6.16M	Buy	+109,760	New	+$6.17M	0.05%	319
2022 Q1	–	Sell	-239,513	Closed	-$13.4M	–	886
2021 Q4	$13.4M	Buy	239,513 +1,319	+0.6%	+$80.6K	0.09%	225
2021 Q3	$15.5M	Sell	238,194 -21,491	-8%	-$1.47M	0.1%	202
2021 Q2	$16.5M	Buy	259,685 +32,250	+14%	+$1.9M	0.11%	206
2021 Q1	$13.6M	Buy	+227,435	New	+$12.4M	0.09%	222

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Silvercrest Asset Management's AXNX Position: Q1 2024 in Review

Silvercrest Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 135,910 shares — an estimated $8.46M sold.

Silvercrest Asset Management first reported a position in AXNX in Q1 2021 and held it in 6 quarters. The position peaked at $16.5M in Q2 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

Silvercrest Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Silvercrest Asset Management sold 135,910 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $8.46M.
Silvercrest Asset Management first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Silvercrest Asset Management's Axonics, Inc. Common Stock position peaked at $16.5M in Q2 2021.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Silvercrest Asset Management's 13F filing for Q1 2024, filed 15 May 2024.